168 related articles for article (PubMed ID: 17846022)
1. HLA-G expression in human ovarian carcinoma counteracts NK cell function.
Lin A; Yan WH; Xu HH; Gan MF; Cai JF; Zhu M; Zhou MY
Ann Oncol; 2007 Nov; 18(11):1804-9. PubMed ID: 17846022
[TBL] [Abstract][Full Text] [Related]
2. Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression.
Lin A; Xu HH; Xu DP; Zhang X; Wang Q; Yan WH
Hum Immunol; 2013 Apr; 74(4):439-46. PubMed ID: 23228395
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of ovarian cancer.
Torres MP; Ponnusamy MP; Lakshmanan I; Batra SK
Minerva Med; 2009 Oct; 100(5):385-400. PubMed ID: 19910891
[TBL] [Abstract][Full Text] [Related]
4. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity.
Sasaki H; Xu XC; Smith DM; Howard T; Mohanakumar T
Transplantation; 1999 Jan; 67(1):31-7. PubMed ID: 9921792
[TBL] [Abstract][Full Text] [Related]
5. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
[TBL] [Abstract][Full Text] [Related]
6. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological significance of HLA-G expression in ovarian cancer.
Sheu JJ; Shih IeM
Semin Cancer Biol; 2007 Dec; 17(6):436-43. PubMed ID: 17681474
[TBL] [Abstract][Full Text] [Related]
8. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself.
Khalil-Daher I; Riteau B; Menier C; Sedlik C; Paul P; Dausset J; Carosella ED; Rouas-Freiss N
J Reprod Immunol; 1999 Jul; 43(2):175-82. PubMed ID: 10479053
[TBL] [Abstract][Full Text] [Related]
9. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
10. High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β.
Ullah M; Azazzen D; Kaci R; Benabbou N; Pujade Lauraine E; Pocard M; Mirshahi M
Neoplasia; 2019 Mar; 21(3):331-342. PubMed ID: 30802770
[TBL] [Abstract][Full Text] [Related]
11. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules.
Poláková K; Bennink JR; Yewdell JW; Bystrická M; Bandzuchová E; Russ G
Hum Immunol; 2003 Feb; 64(2):256-64. PubMed ID: 12559628
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
[TBL] [Abstract][Full Text] [Related]
13. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.
Babay W; Ben Yahia H; Boujelbene N; Zidi N; Laaribi AB; Kacem D; Ben Ghorbel R; Boudabous A; Ouzari HI; Rizzo R; Rebmann V; Mrad K; Zidi I
Hum Immunol; 2018 Jun; 79(6):463-470. PubMed ID: 29499226
[TBL] [Abstract][Full Text] [Related]
15. Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines.
Blottière HM; Zennadi R; Burg C; Douillard JY; Meflah K; Le Pendu J
Int J Cancer; 1992 Feb; 50(4):659-64. PubMed ID: 1537634
[TBL] [Abstract][Full Text] [Related]
16. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.
Lin A; Chen HX; Zhu CC; Zhang X; Xu HH; Zhang JG; Wang Q; Zhou WJ; Yan WH
J Cell Mol Med; 2010 Aug; 14(8):2162-71. PubMed ID: 19799650
[TBL] [Abstract][Full Text] [Related]
17. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity.
Lutz CT; Kurago ZB
Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701
[TBL] [Abstract][Full Text] [Related]
19. HLA-G expression in human melanoma cells: protection from NK cytolysis.
Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
[TBL] [Abstract][Full Text] [Related]
20. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
